Want to track 0O59 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
0O59 closed today higher at €76.69, an increase of 0.0652% from yesterday's close, completing a monthly decrease of -3.9512% or -€3.16. Over the past 12 months, 0O59 stock lost -8.1222%.
0O59 is not paying dividends to its shareholders.
The last earnings report, released on Apr 22, 2026, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.42%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 12 different exchanges and in various currencies, with the primary listing on LSE (EUR).
0O59 Chart
Sanofi SA (0O59) FAQ
What is the stock price today?
The current price is €76.69.
On which exchange is it traded?
Sanofi SA is listed on LSE.
What is its stock symbol?
The ticker symbol is 0O59.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 15.68%.
What is its market cap?
As of today, no market cap data is available.
Has Sanofi SA ever had a stock split?
No, there has never been a stock split.
Sanofi SA Profile
| Pharmaceuticals Industry | Healthcare Sector | Mr. Adam Buchajski CEO | LSE Exchange | FR0000120578 ISIN |
| Poland Country | 88 Employees | 5 May 2026 Last Dividend | - Last Split | - IPO Date |
Sanofi SA is a French multinational pharmaceutical and healthcare company headquartered in Paris, renowned for its research, development, manufacturing, and marketing of innovative medicines and vaccines. Established in 1973, it has evolved through key mergers, including with Synthélabo in 1999 and Aventis in 2004, forming a global leader with over 90,000 employees across 90 countries. Sanofi focuses on seven major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis, and vaccines, positioning it as the world's largest vaccine producer via its Sanofi Pasteur subsidiary. Its portfolio spans prescription drugs like Dupixent for eczema and autoimmune conditions, Lovenox for thrombosis, Taxotere for cancer, and treatments for rare diseases such as Gaucher's and hemophilia. Sanofi also offers over-the-counter products including Allegra and IcyHot. As an R&D-driven, AI-powered biopharma entity, it invests heavily in immunology, neurology, diabetes innovation, and mRNA technologies, maintaining a robust pipeline of 80 compounds in clinical development across five therapeutic areas to address unmet medical needs and advance public health worldwide.
Contact Information
Address: ul. Cisowa 11
Phone: 48 81 444 6480
Website: https://www.holding.sanwil.com
